Logo image
A Model for Predicting Persistent Elevation of Factor VIII among Patients with Acute Ischemic Stroke
Journal article   Peer reviewed

A Model for Predicting Persistent Elevation of Factor VIII among Patients with Acute Ischemic Stroke

Alyana A. Samai, Amelia K. Boehme, Amir Shaban, Alexander J. George, Lauren Dowell, Dominique J. Monlezun, Cindy Leissinger, Laurie Schluter, Ramy El Khoury and Sheryl Martin-Schild
Journal of stroke and cerebrovascular diseases, Vol.25(2), pp.428-435
02/2016
DOI: 10.1016/j.jstrokecerebrovasdis.2015.10.015
PMCID: PMC5022778
PMID: 26777556

View Online

Abstract

Elevated levels of coagulation factor VIII (FVIII) may persist independent of the acute-phase response; however, this relationship has not been investigated relative to acute ischemic stroke (AIS). We examined the frequency and predictors of persistently elevated FVIII in AIS patients. AIS patients admitted between July 2008 and May 2014 with elevated baseline FVIII levels and repeat FVIII levels drawn for more than 7 days postdischarge were included. The patients were dichotomized by repeat FVIII level for univariate analysis at 150% and 200% activity thresholds. An adjusted model was developed to predict the likelihood of persistently elevated FVIII levels. Among 1616 AIS cases, 98 patients with elevated baseline FVIII had repeat FVIII levels. Persistent FVIII elevation was found in more than 75% of patients. At the 150% threshold, the prediction score ranged from 0 to 7 and included black race, female sex, prior stroke, hyperlipidemia, smoking, baseline FVIII > 200%, and baseline von Willebrand factor (vWF) level greater than 200%. At the 200% threshold, the prediction score ranged from 0-5 and included female sex, prior stroke, diabetes mellitus, baseline FVIII level greater 200%, and baseline vWF level greater than 200%. For each 1-point increase in score, the odds of persistent FVIII at both the 150% threshold (odds ratio [OR] = 10.4, 95% confidence interval [CI] 1.63-66.9, P = .0134) and 200% threshold (OR = 10.2, 95% CI 1.82-57.5, P = .0083) increased 10 times. Because an elevated FVIII level confers increased stroke risk, our model for anticipating a persistently elevated FVIII level may identify patients at high risk for recurrent stroke. FVIII may be a target for secondary stroke prevention.
biomarker blood coagulation factor VIII Ischemic stroke thrombosis

Details

Metrics

Logo image